KRTL BioTech

WeWork still on life support, rivals say it must cut costs fast

WeWork still on life support, rivals say it must cut costs fast

SoftBank may be rescuing WeWork with a $9.5 billion cash injection but most rivals say they believe the office space sharing company is still in critical condition.